Rede D'Or Sao Luiz SA
BOVESPA:RDOR3

Watchlist Manager
Rede D'Or Sao Luiz SA Logo
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
Watchlist
Price: 44.1 BRL -7% Market Closed
Market Cap: 101B BRL

Rede D'Or Sao Luiz SA
Investor Relations

Rede D'Or São Luiz SA stands as a prominent figure in Brazil's healthcare landscape, weaving its narrative through a network of hospitals and healthcare facilities that span the country. Founded in 1977, the company has cultivated a robust business model focused on the provision of high-quality, comprehensive healthcare services. It operates through a substantial portfolio of hospitals, oncology clinics, and surgical centers, reflecting a commitment to expanding healthcare accessibility and enhancing patient experiences. The company thrives in a space where it addresses the increasing demand for private healthcare services, driven by an aging population and growing affluence in Brazil.

The financial engine of Rede D'Or is powered by a multifaceted revenue stream predominantly comprising hospitalization and associated medical services. The company strategically leverages its vast infrastructure, clinical excellence, and brand reputation to maintain and grow its market share. Investment in state-of-the-art medical technology and facilities further supports its business model, enhancing operational efficiency and service quality. By offering a diversified range of healthcare services, the company ensures a constant and stable flow of revenue, buttressed by long-term contracts and partnerships with insurance companies. This, in turn, allows Rede D'Or to continually reinvest in expanding its network and upholding the high standards that defined its inception.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2025
Call Date
Nov 6, 2025
AI Summary
Q3 2025

Revenue Growth: Rede D'Or reported Q3 revenue of BRL 15.6 billion, up 10.6% year-on-year.

Profitability: Net income for the quarter reached BRL 1.5 billion, nearly 20% higher than last year.

Operational Efficiency: Record hospital occupancy at 81%, driven by a 21% increase in surgeries, led to strong operational gains.

Oncology Strength: The oncology segment grew revenue by 28.1% year-on-year, reflecting successful integration and expansion.

SulAmérica Performance: SulAmérica added over 70,000 new clients and improved its consolidated loss ratio by 2 percentage points.

Cost Discipline: Administrative expenses fell by 17.2% year-on-year, and company leverage dropped to 1.54x net debt/EBITDA.

Cash Generation: Operational cash flow for the first nine months reached BRL 6 billion, up 22.6%.

Key Financials
Revenue
BRL 15.6 billion
EBITDA
BRL 2.9 billion
Adjusted EBITDA
BRL 3.3 billion
Net Income
BRL 1.5 billion
Operational Cash Flow (9 months)
BRL 6 billion
Leverage (Net Debt/EBITDA)
1.54x
Hospital Occupancy
81%
Surgery Volume
up 21% year-on-year
Oncology Revenue (Q3)
BRL 1.055 billion
Administrative Expenses (Q3)
BRL 253 million
Gross Revenue – Hospital Services (Q3)
BRL 9.3 billion
SulAmérica Net Revenue (Q3)
BRL 8.4 billion
SulAmérica Consolidated Loss Ratio
80.1%
SulAmérica Added Beneficiaries
over 70,000 new clients (68,000 in health, 104,000 in dental)
EBITDA – Hospital Services (Q3)
BRL 2.323 billion
SulAmérica Adjusted EBITDA (Q3)
BRL 1.024 billion
Earnings Call Recording
Other Earnings Calls

Management

Mr. Paulo Junqueira Moll
CEO & Member of Executive Board
No Bio Available
Mr. Otavio de Garcia Lazcano
Member of Executive Board, CFO & Investor Relations Officer
No Bio Available
Mr. Jamil Muanis Neto
Director & Member of Executive Board
No Bio Available
Ms. Raquel Reis Correa Giglio
Member of Executive Board
No Bio Available

Contacts

Address
SAO PAULO
Sao Paulo
Rua Francisco Marengo, n 1.312, Tatuape
Contacts